Press Releases

SAN FRANCISCO--(BUSINESS WIRE)-- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the third quarter and nine months ended September 30, 2018. Recent Highlights Total revenue in

WESTMINSTER, Colo.--(BUSINESS WIRE)-- Brother Mobile Solutions, Inc. (BMS), a provider of award-winning mobile and desktop printers is broadening its successful alliance with Datalogic, a leader in automatic data capture and world-class producer of bar code readers. The two companies will market their mobile scan and print products to meet a growing demand for solutions that increase efficiency and help reduce

NEW YORK--(BUSINESS WIRE)-- The Jackie Robinson Foundation (JRF) will commemorate the one hundredth birthday of its namesake with a year-long schedule of events in 2019 that will benefit the organization’s scholarship and education programs as well as the future Jackie Robinson Museum. As announced today by JRF President Della Britton Baeza, the Foundation will host the year-long

DALLAS--(BUSINESS WIRE)-- Spectra7 Microsystems Inc. (TSX:SEV) (“Spectra7” or the “Company”), a leading provider of high-performance analog semiconductor products for broadband connectivity markets, announced that Molex, a leader in high performance interconnects, has selected Spectra7’s GaugeChanger™ technology for integration into a new line of Active Copper Cables to inclu

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sesen Bio, Inc. (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of people with cancer, today reported operating results for the third quarter ended September 30, 2018 and recent highlights from its development program for Vicinium® for patients with high-grade non-muscle invasive bladder cancer (NM

NORTH HUNTINGDON, Pa.--(BUSINESS WIRE)-- The ExOne Company (Nasdaq: XONE) (“ExOne” or the “Company”), a global provider of three-dimensional (“3D

HILLIARD, Ohio--(BUSINESS WIRE)-- Advanced Drainage Systems, Inc. (NYSE: WMS) (“ADS” or the “Company”), a leading global manufacturer of water management products and solutions for commercial, residential, infrastructure and agricultural applications, today announced that its Board of Directors has approved a quarterly cash dividend to its shareholders in the amount of $0.08 per share.

MINNEAPOLIS--(BUSINESS WIRE)-- Be The Match BioTherapies, an organization offering integrated platfor

GUANGZHOU, China--(BUSINESS WIRE)-- Bio-Thera Solutions, a clinical-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today announced the company will present one poster at the 2018 EORTC-NCI-AACR Symposium taking place November 13 - 16, 2018 in Dublin, Ireland. The poster, entitled “BAT8001, a potent anti-HER2 antibody-drug conj

MALVERN, Pa.--(BUSINESS WIRE)-- PQ Group Holdings Inc. (NYSE:PQG) announced today that it is scheduled to present at Morgan Stanley’s Global Chemicals and Agriculture Conference in Boston on Tuesday November 13, 2018 at 2:00 p.m. ET. There will be a formal presentation followed by a question and answer session. The presentation and question and answer session will be webcast in listen-only mode

BELTSVILLE, Md.--(BUSINESS WIRE)-- NextCure, Inc. a privately-held biopharmaceutical company discovering and developing next generation immunomedicines for cancer and other

SEATTLE--(BUSINESS WIRE)-- Spaceflight, the leading satellite rideshare and mission management provider, today announced it will launch 12 spacecraft in November from India’

LONDON--(BUSINESS WIRE)-- Independent research firm Verdantix has released its sixth annual EHS global survey of 411 decision-makers across 25 industries and 35 countries. The hea

MILTON, N.Y.--(BUSINESS WIRE)-- Sono-Tek Corporation (OTCQX: SOTK), the leading developer and manufacturer of ultrasonic coating systems, announced that it received orde

WALTHAM, Mass.--(BUSINESS WIRE)-- Visterra, Inc., a clinical stage biotechnology company, today announced the initiation of a Phase 1 clinical study with VIS649 in healthy volunteers. VIS649 is a monoclonal antibody targeting the B-cell growth factor APRIL (A Proliferation Inducing Ligand) for the potential treatment of imumuglobulin A nephropathy (IgA nephropathy or IgAN), one of the most common kidney